- Home
- RGC vs BGX Comparison
RGC vs BGX Comparison
Compare RGC & BGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGC | BGX |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 151.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RGC | BGX |
|---|---|---|
| Price | $20.92 | $11.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 325.8K | 67.9K |
| Earning Date | 10-24-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.09 | $10.69 |
| 52 Week High | $83.60 | $12.44 |
Technical Indicators
Market Signals| Indicator | RGC | BGX |
|---|---|---|
| Relative Strength Index (RSI) | 57.60 | 38.17 |
| Support Level | $19.80 | $11.65 |
| Resistance Level | $25.50 | $11.76 |
| Average True Range (ATR) | 2.71 | 0.16 |
| MACD | 0.13 | -0.01 |
| Stochastic Oscillator | 47.37 | 65.63 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About BGX Blackstone Long Short Credit Income Fund
Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. It seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.